ORGANIX, INC.

Company Information

Company Name
ORGANIX, INC.
Address
240 SALEM ST
WOBURN, MA, 01801-
Phone
n/a
URL
n/a
DUNS
161843057
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$3,109,425.00
11
SBIR Phase II
$2,296,515.00
2
Chart code to be here

Award List

  1. Peripheral Narcotic Antagonists--14-Aminomorphinones

    Amount: $100,000.00

    Constipation is the most frequently encountered side effect in the chronic use of opiates to treatthe maintenance of opiate addicts. An opiate antagonist with only peripheral activity, when co-adminwo ...

    SBIR Phase I 1995 Department of Health and Human Services
  2. Spect Imaging Agent for Parkinsons Disease

    Amount: $100,000.00

    There is currently no presymptomatic clinical diagnostic tool for the diagnosis of Parkinson's disedepletion of the dopamine transporter (DAT) in the striatum is a well-established marker of Pd and cd ...

    SBIR Phase I 1995 Department of Health and Human Services
  3. INDOLE ANALOGS AS NOVEL TREATMENTS FOR OCD

    Amount: $109,197.00

    Obsessive Compulsive Disorder (OCD) is a serious mental illness that affects millions of people throughout the world. Existing therapies for OCD show limited efficacy, can possess troubling side effec ...

    SBIR Phase I 2002 Department of Health and Human Services
  4. Indole Analogs as Novel Treatments for OCD

    Amount: $1,464,922.00

    DESCRIPTION (provided by applicant): Obsessive Compulsive Disorder (OCD) is a serious mental illness that affects millions of people throughout the world. Existing therapies for OCD show limited effi ...

    SBIR Phase II 2006 Department of Health and Human Services
  5. Indole Analogs as Novel Appetite Suppressants

    Amount: $559,580.00

    DESCRIPTION (provided by applicant): Obesity affects millions of people in the U.S. and worldwide, and this disease has enormous health and economic consequences for our society. Existing treatments s ...

    SBIR Phase I 2003 Department of Health and Human Services
  6. Novel THC/Anandamide Hybrids as Appetite Suppressants

    Amount: $504,211.00

    Obesity has reached epidemic proportions and in a year about 300,000 people die of obesity-related diseases. Annual medical spending due to obesity and overweight is about $117 billion. There is an ur ...

    SBIR Phase I 2005 Department of Health and Human Services
  7. DESIGN OF A NOVEL COCAINE ANTAGONIST

    Amount: $100,000.00

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  8. CB2 Agonists for Treatment of Neuropathic Pain.

    Amount: $130,505.00

    DESCRIPTION (provided by applicant): Neuropathic pain is a type of chronic pain state caused by injury or disease to the nervous system. Annual medical spending due to pain has been estimated to be o ...

    SBIR Phase I 2008 Department of Health and Human Services
  9. Indole Analogs as Novel Appetite Suppressants

    Amount: $831,593.00

    DESCRIPTION (provided by applicant): Obesity affects millions of people in the U.S. and worldwide, and this disease has enormous health and economic consequences for our society. Existing treatments s ...

    SBIR Phase II 2007 Department of Health and Human Services
  10. Benzodiazepine Analogs as Novel Treatments for Catatonia

    Amount: $686,852.00

    DESCRIPTION (provided by applicant): Catatonia is a widespread and serious syndrome characterized by mutism, stupor, refusal to eat or drink, posturing, and hypokinesis, and affects a broad range of p ...

    SBIR Phase I 2011 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government